Symphony Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-4,609
Closed -$1.01M 216
2018
Q2
$1.01M Sell
4,609
-107
-2% -$24.8K 0.2% 110
2018
Q1
$1.04M Sell
4,716
-2,048
-30% -$481K 0.13% 164
2017
Q4
$1.52M Sell
6,764
-766
-10% -$163K 0.15% 146
2017
Q3
$1.43M Sell
7,530
-56
-0.7% -$10.7K 0.16% 144
2017
Q2
$1.43M Sell
7,586
-371
-5% -$66.7K 0.16% 142
2017
Q1
$1.32M Sell
7,957
-260
-3% -$41.4K 0.12% 172
2016
Q4
$1.18M Sell
8,217
-283
-3% -$37.9K 0.12% 180
2016
Q3
$1.06M Sell
8,500
-9,222
-52% -$1.19M 0.11% 187
2016
Q2
$2.33M Sell
17,722
-1,205
-6% -$165K 0.25% 112
2016
Q1
$2.63M Buy
18,927
+10,651
+129% +$1.42M 0.28% 86
2015
Q4
$1.15M Buy
+8,276
New +$1.14M 0.13% 173
2014
Q2
Sell
-30,500
Closed -$3.04M 415
2014
Q1
$3.04M Buy
+30,500
New +$2.76M 0.29% 97
2013
Q4
Sell
-138,500
Closed -$11.6M 467
2013
Q3
$11.6M Buy
+138,500
New +$11.9M 1.17% 23

Other funds holding ELV

Symphony Asset Management's ELV Position: Q3 2018 in Review

Symphony Asset Management sold out of Elevance Health (ELV) in Q3 2018, closing a stake of 4,609 shares — an estimated $1.01M sold.

Symphony Asset Management first reported a position in ELV in Q3 2013 and held it in 13 quarters. The position peaked at $11.6M in Q3 2013. 947 funds tracked by Wall St. Rank hold ELV as of Q3 2018.

  • Symphony Asset Management reported no remaining Elevance Health position as of Q3 2018 after selling out during the quarter.
  • Symphony Asset Management sold 4,609 Elevance Health shares in Q3 2018, an estimated $1.01M.
  • Symphony Asset Management first reported a position in Elevance Health in Q3 2013 and held it in 13 quarters.
  • Symphony Asset Management's Elevance Health position peaked at $11.6M in Q3 2013.
  • 947 funds tracked by Wall St. Rank held Elevance Health as of Q3 2018.

Based on Symphony Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.